Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ifosfamide in pediatric oncology.

P A Voûte1, J de Kraker

  • 1University of Amsterdam Werkgroep Kindertumoren, Emma Kinderziekenhuis, Academic Medical Centre, The Netherlands.

Seminars in Oncology
|February 1, 1992
PubMed
Summary

Ifosfamide effectively treats pediatric solid tumors, including blastomas and sarcomas. However, potential side effects include kidney damage in young children and gonadal damage in older boys.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainability assessment as problem structuring: three typical ways.

Sustainability science·2018
Same author

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

European journal of cancer (Oxford, England : 1990)·2015
Same author

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study.

British journal of cancer·2014
Same author

Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Incidence and outcomes of patients with late recurrence of Wilms' tumor.

Pediatric blood & cancer·2013
Same author

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

British journal of cancer·2008

Area of Science:

  • Pediatric Oncology
  • Medical Chemistry

Background:

  • Ifosfamide is a chemotherapy agent used in treating various pediatric cancers.
  • It is commonly administered as part of combination chemotherapy regimens.

Purpose of the Study:

  • To evaluate the efficacy and side effect profile of ifosfamide in pediatric cancer treatment.

Main Methods:

  • Review of clinical data on pediatric patients treated with ifosfamide.
  • Analysis of treatment outcomes and adverse events.

Main Results:

  • Ifosfamide demonstrates effectiveness against pediatric solid tumors, blastomas, and sarcomas.
  • Nephrotoxicity is a significant concern in younger children.
  • Gonadal damage is a notable late-onset side effect in older male patients.

Conclusions:

  • Ifosfamide is a valuable therapeutic option for specific pediatric malignancies.
  • Careful monitoring for nephrotoxicity and gonadal damage is crucial during and after treatment.

Related Experiment Videos